β-Adrenoceptor ligand binding and supersensitivity to isoprenaline of ventricular muscle after chronic reserpine pretreatment
Isolate papillary muscles from guinea-pig hearts were paced at a constant frequency and isometric contractions recorded.
Guinea-pigs were either untreated or pretreated with reserpine. Three pretreatment schedules were used; a) 0.5 mg kg−1 i.p. at 24h, b) 5.0 mg kg−1 at 72h and 3.0 mg kg−1 at 48 and 24 h, or c) 0.1 mg kg−1 daily for 7 days.
Cumulative concentration-response curves for the isoprenaline-induced increases in tension were obtained. The geometric mean EC50 values after the 3 and 7 day reserpine pretreatment schedules were significantly (P<0.05) less than for untreated guinea-pigs indicating a supersensitivity.
EC50 values for the positive inotropic inotropic responses to histamine and calcium in papillary muscles from reserpine-pretreated guinea-pigs did not differ significantly (P<0.05) from those from untreated animals. This suggests that the supersensitivity to isoprenaline is β-adrenoceptor specific.
Membrane fractions were prepared from the ventricles of the untreated and reserpine-pretreated guinea-pigs from which papillary muscles had been removed. Binding of [3H]-dihydroalprenolol ([3H]-DHA) to β-adrenoceptors of these membranes was determined. Equilibrium dissociation constants (KD) and total numbers of binding sites (Bmax) were determined by Scatchard analysis of the saturation curves for [3H]-DHA binding.
There was no increase in affinity (fall in KD value) or change in the total number of binding sites associated with reserpine-induced supersensitivity. The equilibrium inhibition constant (Ki) for the displacement of [3H]-DHA binding by isoprenaline was also identical in membranes from untreated and reserpine-pretreated animals. Thus reserpine-induced supersensitivity to isoprenaline does not appear to involve a change in affinity for the β-adrenoceptor or in receptor numbers as determined by [3H]-DHA binding.
Key wordsCardiac β-adrenoceptors Reserpine Supersensitivity Papillary muscle [3H]-Dihydroalprenolol
Unable to display preview. Download preview PDF.
- Broadley KJ, Lumley P (1977) Selective reserpine-induced supersensitivity of the positive inotropic and chronotropic responses to isoprenaline and salbutamol in guinea-pig isolated atria. Br J Pharmacol 59:51–60Google Scholar
- Broadley KJ, Nicholson CD (1980) The use of an irreversible β-adrenoceptor antagonist to examine reserpine and hypothermia-induced supersensitivity. J Autonomic Pharmacol 1:27–35Google Scholar
- Chiu TH (1978) Chronic effects of 6-hydroxydopamine and reserpine on myocardial adenylate cyclase. Eur J Pharmacol 52:385–388Google Scholar
- Fleming WW, Trendelenburg U (1961) The development of supersensitivity to norepinephrine after pretreatment with reserpine. J Pharmacol Exp Ther 133:41–51Google Scholar
- Green RD, Fleming WW (1967) Agonist-antagonist interactions in the normal and supersensitive nictitating membrane of the spinal cat. J Pharmacol Exp Ther 156:207–214Google Scholar
- Hudgins PM, Fleming WW (1966) A relatively non-specific supersensitivity in aortic strips resulting from pretreatment with reserpine. J Pharmacol Exp Ther 153:70–80Google Scholar
- Jurevics HA, Carrier O Jr (1973) The influence of reserpine on the calcium-induced responses of spontaneously beating isolated rabbit atria. J Pharmacol Exp Ther 184:189–197Google Scholar
- Kent RS, De Lean A, Lefkowitz RJ (1980) A quantitative analysis of beta-adrenergic receptor interactions: Resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol Pharmacol 17:14–23Google Scholar
- Koch-Weser J, Blinks JR (1963) The influence of the interval between beats on myocardial contractility. Pharmacol Rev 15:601–652Google Scholar
- Lefkowitz RJ, Hoffman BB (1981) New directions in adrenergic receptor reasearch. In: Lamble JW (ed) Towards understanding receptors. Current reviews in biomedicine 1. Elsevier North Holland Biomedical Press, Amsterdam, pp 61–70Google Scholar
- Lowry OH, Rosebrough NJ, Farr, AL, Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193: 265–275Google Scholar
- McNeill JH (1969) Researpine supersensitivity to catecholamine-induced cardiac phosphorylase activation. Can J Physiol Pharmacol 47: 515–519Google Scholar
- McNeill JH, Schulze S (1972) Reserpine-induced supersensitivity to histamine activated cardiac phosphorylase and cardiac contractility. Res Commun Chem Pathol Pharmacol 3:339–347Google Scholar
- Meisheri DK, Tenner TE Jr, McNeill JH (1979) Reserpine-induced supersensitivity to the cardiac effect of agonists. Life Sci 24:473–480Google Scholar
- Nohorski SR (1977) Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3′, 5′-monophosphate formation and [3H] propranolol binding. Mol Pharmacol 13:679–689Google Scholar
- Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672Google Scholar
- Taylor DA, Westfall DP, Fleming WW (1974) The effect of reserpine treatment on the chronotropic an dinotropic sensitivities of the perfused guinea-pig heart to norepinephrine and calcium. Eur J Pharmacol 29:102–108Google Scholar
- Taylor J, Green RD (1971) Analysis of reserpine sensitivity in aortic strips of rabbits. J Pharmacol Exp Ther 177:127–135Google Scholar
- Tenner TE Jr (1976) The influence of reserpine pretreatment on the caradiac sensitivities to calcium. Ph. D. Thesis, University of Texas Health Sciences Center at San AntonioGoogle Scholar
- Tenner TE Jr (1979) Reserpine induced cardiac supersensitivity. Proc West Pharmacol Soc 22:1–4Google Scholar
- Tenner TE Jr, Cerrier O Jr (1978) Reserpine induced supersensitivity to the chronotropic and inotropic effects of calcium on rabbit atria. J Pharmacol Exp Ther 205:183–192Google Scholar
- Tenner TE Jr, McNeill JH, Carrier O Jr (1978) The role of calcium in supersensitivity to the inotropic effects of norepinephrine. Eur J Pharmacol 50:359–367Google Scholar
- U'Prichard CD, Snyder SH (1978) 3H-catecholamine binding to α-receptors in rat brain: enhancement by researpine. Eur J Pharmacol 51: 145–155Google Scholar
- Waud DR, Kattegada SR, Krayer O (1958) Threshold dose and time course of norepinephrine depletion of the mammalian heart by reserpine. J Pharmacol Exp Ther 124:340–346Google Scholar
- Westfall DP, Fleming WW (1968) Sensitivity changes in the dog heart to norepinephrine, calcium and aminophylline resulting from pretreatment with reserpine. J Pharmacol Exp Ther 159:98–106Google Scholar